Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis
- 22 July 2003
- journal article
- Published by Elsevier BV in Bone
- Vol. 33 (2), 216-228
- https://doi.org/10.1016/s8756-3282(03)00223-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Osteosarcomas and other cancers of boneCurrent Opinion in Oncology, 2000
- Cellular and molecular mechanisms of action of bisphosphonatesCancer, 2000
- Farnesol and Geranylgeraniol Prevent Activation of Caspases by Aminobisphosphonates: Biochemical Evidence for Two Distinct Pharmacological Classes of Bisphosphonate DrugsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1999
- Clodronate and Liposome-Encapsulated Clodronate Are Metabolized to a Toxic ATP Analog, Adenosine 5′-(β,γ-Dichloromethylene) Triphosphate, by Mammalian Cells In VitroJournal of Bone and Mineral Research, 1997
- Bone mass homeostasis and bisphosphonate actionBone, 1997
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.JCI Insight, 1993
- Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.JCI Insight, 1991
- Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow.JCI Insight, 1989
- Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonateJournal of Bone and Mineral Research, 1988